Family Practice Associates of Clarksville,pa
Family Practice Associates of Clarksville,pa was paid $2.25M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoFAMILY PRACTICE ASSOCIATES OF CLARKSVILLE,PA
CLARKSVILLE, AR 72830
CLARKSVILLE, AR 72830
33aNPI1518957240assigned 10/25/2005
33bProvider typeLegal Medicine
28Total paid$2.25M
24GClaims80,888
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,447 | $322K | |
| 2019 | 12,695 | $367K | |
| 2020 | 10,242 | $283K | |
| 2021 | 10,696 | $289K | |
| 2022 | 13,328 | $406K | |
| 2023 | 12,461 | $336K | |
| 2024incomplete | 8,019 | $243K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 29,019 | 25,559 | $952K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 5,817 | 5,360 | $295K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 9,640 | 8,874 | $246K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.6% | 2,052 | 1,912 | $215K |
| 99406 | 6.0% | 10,851 | 9,375 | $134K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.5% | 1,709 | 1,635 | $78K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 1,219 | 1,137 | $58K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.5% | 1,106 | 1,054 | $56K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.5% | 906 | 863 | $33K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,150 | 1,068 | $29K |
| 80061 | Lipid panel | 1.0% | 2,710 | 2,497 | $23K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 432 | 395 | $20K |
33 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,858 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 2,119 | $12K |
| 80050 | General health panel | <1% | 288 | $12K |
| 87634 | <1% | 110 | $9K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 145 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 108 | $6K |
| 90686 | <1% | 679 | $6K | |
| 71020 | <1% | 165 | $5K | |
| 87275 | <1% | 379 | $4K | |
| 87276 | <1% | 379 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 564 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 272 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 526 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 254 | $3K |
| 90688 | <1% | 235 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 104 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 298 | $2K |
| 82607 | <1% | 104 | $968.40 | |
| 81001 | <1% | 183 | $502.68 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17 | $477.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 108 | $382.50 |
| 74018 | <1% | 12 | $313.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,405 | $295.73 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 104 | $223.95 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 38 | $132.00 |
| 82570 | <1% | 47 | $118.24 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 27 | $81.22 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 167 | $75.94 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $71.04 |
| 82044 | <1% | 63 | $59.62 | |
| 99000 | <1% | 463 | $52.58 | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 15 | $22.40 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 28 | $9.76 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRATT, DARLENE (ADMINISTRATOR)